ReviewDEN open2024
Recurrence of common bile duct stones after endoscopic clearance and its predictors: A systematic review.
Review in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 15 citations in OpenAlex.
- SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone Management.Yonsei medical journal · 2026Trial
- Papillary Balloon Dilation Versus Sphincterotomy for Small Common Bile Duct Stones: Recurrence and Pneumobilia in a Retrospective Cohort.Digestive diseases and sciences · 2026Article
- Age-Associated Differences in Ductal Involvement in Biliary Lithiasis: A Consecutive MRCP Cohort Study.Life (Basel, Switzerland) · 2026Article
- Single-stage versus two-stage ERCP and laparoscopic cholecystectomy for gallbladder stones with choledocholithiasis: a retrospective cohort study with long-term prognostic comparative analysis.BMC gastroenterology · 2026Article
- Endoscopic Retrograde Cholangiopancreatography (ERCP) Under the Spotlight.Digestive diseases and sciences · 2026Article
- Recurrent choledocholithiasis after laparoscopic bile duct exploration: incidence, risk factors, and management strategies.Surgical endoscopy · 2026Article
- Comparative Outcomes of Endoscopic Treatment for Symptomatic and Asymptomatic Common Bile Duct Stones in the Elderly: A Propensity Score-Based Cohort Analysis.Journal of hepato-biliary-pancreatic sciences · 2026Article
- Deeper sedation during ERCP is associated with fewer retained common bile duct stones: a prospective population-based register study.BMC gastroenterology · 2026Observational
- Cholangioscopy-assisted ERCP reduces radiation exposure in treating choledocholithiasis: a retrospective IPTW-adjusted cohort study.Frontiers in medicine · 2026Article
- Recurrent ascending cholangitis secondary to food reflux following transduodenal resection of an ampullary adenoma.Annals of the Royal College of Surgeons of England · 2026Article
- Article
- Recurrent choledocholithiasis following multiple failed endoscopic retrograde cholangiopancreatographies: a case for laparoscopic choledochoduodenostomy.Journal of surgical case reports · 2025Article
- Laparoscopic common bile duct exploration for common bile duct stones after gastric surgery.Surgical endoscopy · 2025Observational
- NXT629 Ameliorates Cholesterol Gallstones in Mice Model by Improving Lipid Metabolism Disorder and Cholesterol Homeostasis Through Inhibiting the GPAM Pathway.Digestive diseases and sciences · 2025Article
- Laparoscopic cholecystectomy plus common bile duct exploration for extrahepatic bile duct stones and postoperative recurrence-associated risk factors.World journal of gastrointestinal surgery · 2024Article
- Efficacy of Endoscopic Isolated Papillary Small Balloon Dilation for Treating Choledocholithiasis.JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The primary therapeutic strategy for the management of bile duct stones (BDS) is endoscopic retrograde cholangiopancreatography. However, there may be a recurrence of BDS on follow-up. Multiple risk factors have been studied for the prediction of BDS recurrence. We aimed to analyze the incidence of symptomatic BDS recurrence, systematically review the risk factors, and analyze the most important risk factors among those. Methods: A comprehensive search of three databases was conducted from inception to November 2022 for studies reporting the recurrence of BDS recurrence after endoscopic retrograde cholangiopancreatography with clearance, along with an analysis of risk factors. Results: A total of 37 studies with 12,952 patients were included in the final analysis. The pooled event rate for the recurrence of BDS stones was 12.6% (95% confidence interval: 11.2-13.9). The most important risk factor was a bile duct diameter ≥15 mm, which had a significant association with recurrence in twelve studies. Other risk factors with significant association with recurrence in three or more studies were the reduced angulation of the bile duct, the presence of periampullary diverticulum, type I periampullary diverticulum, in-situ gallbladder with stones, cholecystectomy, multiple stones in the bile duct, use of mechanical lithotripsy, and bile duct stent placement. Conclusion: Around one out of seven patients have BDS recurrence after the initial endoscopic retrograde cholangiopancreatography. Bile duct size and anatomy are the most important predictors of recurrence. The assessment of risk factors associated with recurrence may help keep a close follow-up in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.